Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionForsta Ap-fonden
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Forsta Ap-fonden closes position in VRTX / Vertex Pharmaceuticals Incorporated

On May 7, 2026 - Forsta Ap-fonden filed a 13F-HR form disclosing ownership of 0 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 53,480 shares of Vertex Pharmaceuticals Incorporated. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F Vertex Pharmaceuticals COM 92532F100 0 -100.00 0
2026-02-10 2025-12-31 13F Vertex Pharmaceuticals COM 92532F100 53,480 -1,520 -2.76 24,246 12.56 0.1445
2025-11-10 2025-09-30 13F Vertex Pharmaceuticals COM 92532F100 55,000 3,000 5.77 21,540 -6.95 0.1278
2025-08-08 2025-06-30 13F Vertex Pharmaceuticals COM 92532F100 52,000 -6,200 -10.65 23,150 -17.95 0.1522
2025-05-12 2025-03-31 13F Vertex Pharmaceuticals COM 92532F100 58,200 -500 -0.85 28,217 19.37 0.2136
2025-01-23 2024-12-31 13F Vertex Pharmaceuticals COM 92532F100 58,700 -1,200 -2.00 23,638 -15.15 0.1679
2024-10-24 2024-09-30 13F Vertex Pharmaceuticals COM 92532F100 59,900 6,000 11.13 27,858 10.27 0.2142
2024-08-08 2024-06-30 13F Vertex Pharmaceuticals COM 92532F100 53,900 -1,800 -3.23 25,264 8.51 0.2240
2024-05-07 2024-03-31 13F Vertex Pharmaceuticals COM 92532F100 55,700 -18,000 -24.42 23,283 -22.36 0.1972
2024-02-06 2023-12-31 13F Vertex Pharmaceuticals COM 92532F100 73,700 600 0.82 29,988 17.97 0.3030
2023-10-25 2023-09-30 13F Vertex Pharmaceuticals COM 92532F100 73,100 1,000 1.39 25,420 0.19 0.2837
2023-08-03 2023-06-30 13F Vertex Pharmaceuticals COM 92532F100 72,100 2,400 3.44 25,373 15.54 0.2731
2023-04-21 2023-03-31 13F Vertex Pharmaceuticals COM 92532F100 69,700 8,300 13.52 21,960 23.85 0.2581
2023-02-02 2022-12-31 13F Vertex Pharmaceuticals COM 92532F100 61,400 6,600 12.04 17,731 11.75 0.2002
2022-10-17 2022-09-30 13F Vertex Pharmaceuticals COM 92532F100 54,800 900 1.67 15,867 4.47 0.1942
2022-08-11 2022-06-30 13F Vertex Pharmaceuticals COM 92532F100 53,900 -3,600 -6.26 15,188 1.21 0.1977
2022-05-09 2022-03-31 13F Vertex Pharmaceuticals COM 92532F100 57,500 -19,800 -25.61 15,006 -11.60 0.1705
2022-02-11 2021-12-31 13F Vertex Pharmaceuticals COM 92532F100 77,300 1,100 1.44 16,975 22.81 0.1712
2021-11-10 2021-09-30 13F Vertex Pharmaceuticals COM 92532F100 76,200 -2,100 -2.68 13,822 -12.45 0.1566
2021-08-12 2021-06-30 13F/A-1 Vertex Pharmaceuticals COM 92532F100 78,300 18,300 30.50 15,788 22.45 0.1858
2021-08-12 2021-06-30 13F Vertex Pharmaceuticals COM 92532F100 60,000 0 12,893 0.1805
2021-05-11 2021-03-31 13F Vertex Pharmaceuticals COM 92532F100 60,000 -11,300 -15.85 12,893 -23.49 0.1805
2021-02-09 2020-12-31 13F Vertex Pharmaceuticals COM 92532F100 71,300 12,900 22.09 16,851 6.03 0.2541
2021-02-19 2020-09-30 13F/A-1 Vertex Pharmaceuticals COM 92532F100 58,400 23,100 65.44 15,892 55.07 0.3283
2020-10-22 2020-09-30 13F Vertex Pharmaceuticals COM 92532F100 58,400 23,100 15,892 523,101.4531
2020-08-11 2020-06-30 13F Vertex Pharmaceuticals COM 92532F100 35,300 4,000 12.78 10,248 37.59 0.2697
2020-05-04 2020-03-31 13F Vertex Pharmaceuticals COM 92532F100 31,300 31,300 7,448 0.2673
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.